Stock 6617 GONGWIN BIOPHARM HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Gongwin Biopharm Holdings Co., Ltd.

Equities

6617

KYG409471060

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
153 TWD +3.73% Intraday chart for Gongwin Biopharm Holdings Co., Ltd. +19.07% -17.07%
14/05 Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
08/05 Gongwin Biopharm Co., Ltd. announced that it expects to receive TWD 300 million in funding from Gongwin Biopharm Holdings Co., Ltd. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Gongwin Biopharm Co., Ltd. announced that it expects to receive TWD 300 million in funding from Gongwin Biopharm Holdings Co., Ltd.
CI
Gongwin Biopharm Holdings Co., Ltd.' Subsidiary Gongwin Pharmaceutical Technology Co., Ltd. Receives Letter from Taiwan?s Ministry of Health and Welfare Approving New Drug PTS100 for the Compassionate Treatment
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Gongwin Biopharm Holdings Co., Ltd.(GTSM:6617) added to S&P Global BMI Index
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019
CI
Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6617 Stock
  4. News Gongwin Biopharm Holdings Co., Ltd.